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Summal'~ 
Rat  T  lymphocytes,  activated in vitro with concanavalin A  (Con A), were shown by flow 
cytofluorographic analysis to contain a population of cells that simultaneously expressed CD4 
and the ol chain of CD8. The inclusion of the glucocorticoid hormone dexamethasone in the 
culture medium greatly increased both the frequency of these double-positive cells and the level 
of CD8ot chain expression. The level of expression of CD4 was not affected, and the cells that 
expressed CD8 antigen only also remained unchanged in surface phenotype. Detailed  studies 
demonstrated unequivocally that the CD4+CD8ot + cells were not artifacts produced by the 
random association of single-positive cells in the flow cytofluorograph, but arose from precursors 
that  were single-positive  CD4 + cells before  activation.  Furthermore, Con A  activation  of 
purified CD4 + T cells, in the presence of T cell-depleted  accessory cells, showed that CD8 + 
T cells played no role in the induction process. However, the induction of CD8ot chain expression 
on  CD4 + T  cells and  the enhancement of this  expression by dexamethasone  were almost 
completely  inhibited by rat recombinant interleukin 4 (IL-4). Detection of mRNA for rat CDSot 
chain by Northern blot closely paralleled the cell surface expression of CDSol antigen, indicating 
that  dexamethasone  and II.~4 had  opposing  effects on mRNA levels. In contrast,  IL-4 and 
dexamethasone both induced CD8ot chain expression on a rat CD4 § T  cell clone when this 
was activated by specific antigen, and, although the effect with II--4 was relatively weak, it did 
not antagonize the effect of the glucocorticoid. The possible significance of these results is briefly 
discussed. 
G 
lucocorticoids are widely used as immunosuppressive and 
antiinflammatory agents.  Their  immunosuppressive 
effects, although not well understood, probably  depend in 
part on their property of depressing the expression of many 
interleukin genes (1-3). However, not all the effects of gluco- 
corticoids are inhibitory.  It has recently been reported that 
they enhance the synthesis of IgE when added to cultures 
of B cells containing Ib4 (4) and induce the expression of 
several cytokine receptors on various mononuclear cells (5-8). 
These observations suggest that the overall effect of these hor- 
mones will depend on both positive and negative actions. 
Cell surface expression of CD4 and CD8 molecules di- 
vides mature T cells into two functionally different subsets. 
The majority of normal peripheral T  lymphocytes express 
either CD4 or CD8 antigens,  although a small percentage 
of circulating lymphocytes coexpress CD4 and CD8 (9). This 
circulating  double-positive population consists of lympho- 
blasts, suggesting that CD4 and CD8 coexpression on ma- 
ture T cells is related to activation. In accordance with this 
observation,  it has been shown in humans (9,  10) and rats 
(11) that a CD4+CD8 + population is generated after acti- 
vation of T lymphocytes by mitogen or MLR. The genera- 
tion in vivo of a double-positive population has been reported 
in the rat after activation in several ways: in the spleen of 
rats primed with dinitrophenyl bovine gamma globulin (12), 
in the blood of cyclosporine-treated  heart-allografted rats (13), 
in the peritoneal exudate from rats immune to a syngeneic 
rat mammary adenocarcinoma (14), and in the thoracic duct 
lymph of animals undergoing GVHD (D. Mason,  unpub- 
lished results). In humans there are similar findings: the exis- 
tence of a double-positive population has been described in 
patients with rheumatoid arthritis (15) and after renal trans- 
plantation (16). These reports suggest that after activation, 
in vivo or in vitro,  some T  cells develop a transient  stage 
characterized by CD4  and CD8  coexpression,  an unusual 
phenotype in mature T cells. It should be pointed out, how- 
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positive T  cells after activation,  and it has been suggested 
that the majority of these cells may be artifacts produced by 
association  of single-positive cells during  flow cytofluoro- 
graphic analysis  (17). 
Our initial aim was to examine the action of glucocorti- 
coids during  T  cell activation,  specifically asking  whether 
there is a different effect upon  CD4 +  and  CD8 +  T  cells. 
Surprisingly, we observed a very extensive overlap in the per- 
centages of CD4 + and CD8 + populations after mitogen ac- 
tivation in the presence of the glucocorticoid analogue dexa- 
methasone, suggesting that a very large population expressing 
both cell surface molecules was being generated. Using two- 
color immunoftuorescence analysis, we have demonstrated that 
CD4 + single-positive cells are the precursors of the double- 
positive ones.  This latter population probably arises by de 
novo biosynthesis of CD8c,, because we can detect CDSce-spe- 
cific mRNA in T cells that, before activation, were virtually 
all CD4 + CDS-.  We also show the existence of hormonal 
and lymphokine regulation for the transient  expression of 
CDSoe in  CD4 §  T  cells,  with  glucocorticoids increasing, 
and IL-4 decreasing, the levels of expression. The possible in 
vivo relevance of these observations  is discussed. 
Materials  and Methods 
Animals.  PVG.RT1  c,  PVG.RT1  u,  and  PVG.RT7  b strain rats 
were from the specific pathogen-free unit of the Medical Research 
Council Cellular Immunology Unit. 
Antibodies.  mAbs used in this work were as follows: W3/25 
(anti-rat CD4) (18). MRC-OX35 (anti-rat CD4 noncompetitive 
with W3/25) (19), MRC-OX8 and MRC-OX9 (anti-rat CD8) 
(20), MRC-OX12 (anti-rat Ig r chain) (21), MRC-OX6 (anti-rat 
MHC class II) (22), MRC-OX22 (anti-rat CD45-restricted deter- 
minant) (23), MRC-OX32 (anti-rat CD45-restricted determinant 
noncompetitive with OX22) (24),  NDS58 (anti-rat CD45 allo- 
type RT7  ~)  (25),  HIS 41  (anti-rat  CD45  allotype RT7  b)  (26), 
MRC-OX21  (anti-human  C3b inactivator) (27),  and mAb 341 
(reactive with rat CD8 heterodimers but not with CD8c~ chain) 
(28).  Biotinylated mAbs were prepared as described (29). 
Rat Recombinant Interleukins and Other Reagents.  Tissue culture 
superuatants containing either rat rlL-2 or rat rlL-4 were obtained 
from stably transfected Chinese hamster ovary (CHO) cell lines, 
generated using the rat I1--2 (30) or rat IL-4 (31) cDNA inserts sub- 
cloned into the pEE6.HCMV-GS expression vector (32). Superua- 
tants from mock-transfected CHO cells served as controls in each 
of the experiments. Rat rIFN-~ was the generous gift of Dr. P. 
van der Meide (Primate Centre TNO, Rijswijk, The Netherlands). 
Dexamethasone (Sigma Chemical Co., St. Louis, MO) was stored 
as a stock solution at  10 .2 M  in ethanol, and was  diluted into 
complete media just before its addition to culture. 
Cells.  Rat thoracic duct lymphocytes (TDL) were obtained by 
cannulation of the duct (33). Cells were collected at 4~  overnight 
into flasks containing PBS and 20 U/ml heparin. Spleens were re- 
moved aseptically from rats, and the cells were isolated by pressing 
fragments of the tissue through a stainless steel mesh into ice-cold 
PBS containing 0.2% BSA. Myelin basic protein 3 (MBP-3) 1 is a 
MBP-spedfic CD4 + T  cell line; its production and maintenance 
have been previously described (34). 
Isolation of Subsets of Lymphocytes.  Subpopulations  of TDL, 
1 Abbreviation used in this paper: MBP, myelin basic protein. 
lymph node cells, and splenocytes were purified by negative selec- 
tion using the rosetting technique (29).  T cells were purified by 
removing cells expressing OX12 and OX6 antigens.  CD4 + T cells 
were isolated by depletion of the OX12 +, OX6+, and OX8 + cells. 
CD8 + T cells were obtained using the mAbs W3/25, OX35, and 
OX6. T cell-depleted splenocytes, used as accessory cells, were pre- 
pared by depletion of W3/25-,  OX35-,  and OXS-positive cells. 
OX22~ShCD4 + and OX221~  subpopulations  were obtained 
by cell fractionation using a FACSII  |  (Becton Dickinson & Co., 
Mountain View, CA), after labeling of isolated CD4 + cells with 
the mAbs OX22 and OX32,  and FITC-conjugated rabbit anti- 
mouse Ig. After all fractionation procedures,  cell purities were as- 
sessed by labeling pre- and postdepletion samples with rabbit anti- 
mouse FITC and analyzing on a FACScan  |  flow cytofluorograph 
(Becton Dickinson & Co.). Purities were always 97-99%. 
Cell Cultures.  Cells were stimulated with 5/zg/ml Con A in 
RPMI containing 10 -s M 2-ME, 5% FCS, and antibiotics,  in the 
presence of T cell-depleted splenocytes as accessory cells preirradi- 
ated with 2,000 rad 137Cs "y irradiation.  After a 3-d incubation 
period, cells were harvested and prepared for FACS  |  analysis or 
RNA isolation. The MBP-3 cell line was maintained by a cycle 
of 3 d of antigen stimulation (MBP at 20/zg/ml) in the presence 
of irradiated syngeneic thymocytes, followed by 10 d resting in the 
presence of rlL-2. Cells were separated over a Ficoll-Hypaque den- 
sity gradient at the beginning of the activation period and before 
FACS  |  analysis. 
Immunofluorescence Staining and Analysis.  Viable lymphocytes, 
isolated at the end of the culture period, were incubated with 50 
#1 of tissue culture supernatant from the appropriate hybridoma 
culture, washed twice, and then incubated with fluoresceinated 
rabbit F(ab')2 anti-mouse IgG antibody in the presence of 10% 
normal rat serum to avoid anti-rat Ig crossreactivity. The cells were 
washed again and then analyzed on a FACScan  |  The irrelevant 
mAb MRC OX21 was used as a control for specificity. To carry 
out two-color flow cytofluorography, the cells were incubated with 
the mouse mAb, washed, and then incubated with fluoresceinated 
Fab anti-mouse Ig antibody. After two further washes,  the cells 
were incubated with the corresponding biotinylated mAb, followed, 
after two additional washes, by PE-conjugated streptavidin. At the 
end of this incubation period, unconjugated biotin, a final concen- 
tration of 3/zg/ml, was added to reduce cell aggregation after cen- 
trifugation. After 10 min of incubation with the biotin, the cells 
were given a final wash and analyzed on the FACScan  | 
Northern Blot Analysis.  Total cellular RNA was prepared by a 
guanidinium thiocyanate-phenol-chloroform extraction technique 
(35),  and 20/zg of each sample was  subjected  to electrophoresis 
through a denaturating 1.2% agarose gel. The RNA was trans- 
ferred to a Genescreen Plus  membrane (New England Nuclear, 
Boston,  MA)  and  probed  with  a  32p-labeled HindlII/EcoKI 
cDNA fragment encoding the carboxyl terminus of the rat CD8c~ 
chain (36). The membrane was stripped and reprobed with a 607- 
bp cDNA fragment derived from the rat fl actin gene sequence 
(37) generated by using the PCR. After hybridization, membranes 
were washed with  lx  SSC/1%  SDS  at  60~  and  exposed to 
Hyperfilm-MP  (Amersham  International,  Amersham,  UK)  at 
-  70oC. 
Results 
Dexamethasone Potentiates  the Generation of a CD4 +  CD8 + 
Population  during Mitogen Activation.  To study the effect of 
glucocorticoids on the expression of CD4 and CD8 on rat 
T  cells,  normal spleen cells were activated with  Con A  in 
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Figure 1.  Con A activation  of rat T lymphocytes  results 
in the appearance  of  cells expressing  both CD4 and CD8, 
and dexamethasone  increases  the frequency  of these double- 
positive cells. Purified rat T cells were stimulated in vitro 
for 72 h with Con A using irradiated, T call-depleted 
splenocytes  as accessory  calls. Dexamethasone  was included 
in the culture medium in some cases. After culture two- 
color cytofluorographic  analysis  was carried  out using anti- 
CD4 and anti-CD8 mAbs. Cells cultured: (A) Con A 
alone; (/3) Con A plus 10-s M dexamethasone; (C) Con 
A plus 10 -6 M dexamethasone. 
the absence or presence of dexamethasone. The inclusion of 
the hormone in the culture resulted in a marked increase in 
the number of cells expressing CD8,  and an overlap in the 
percentages of CD4 + and CD8 + cells.  To further investigate 
this phenomenon, purified T  cells were activated with Con 
A using T cell-depleted splenocytes as feeder cells, in the pres- 
ence of 10 -6 or  10 -s M  dexamethasone,  considered phar- 
macological and physiological glucocorticoid concentrations, 
respectively. Two-color immunofluorescence analysis was car- 
ried out after a 3-d incubation period.  Fig.  1 A  shows the 
result  of activating T  cells with  Con A  alone. 
The CD4 + CD8 + double-positive population detected in 
this experiment amounted to 16% of the total cells analyzed. 
This percentage varied between different experiments,  and 
sometimes  the  size of the double-positive population  was 
markedly higher (see Fig.  3).  Fig.  1, B  and  C,  show that 
including dexamethasone in the culture increased the number 
of the CD4 + CD8 + cells, and that this effect was dose de- 
pendent:  10 -6 M  induced a higher percentage (42%)  than 
10 -s M  (27%). As in some previous reports (9, 11), it was 
observed that the CD4 + CD8 + population, induced by a 3-d 
incubation of T  cells in Con A  alone, decreased with time 
if the Con A was removed and the cells were maintained in 
a proliferative state by the addition of Ib2. However, if the 
initial 3-d stimulation with Con A was made in the presence 
of dexamethasone and the subsequent culture was in II~2 alone, 
then the frequency of double-positive cells actually increased 
significantly,  suggesting  that  the level of steroid hormone 
present at the time of activation was important in determining 
the longer  term behavior of the cells (data not  shown). 
The CD4 +  CD8 + Population  Derives from  CD4 +  CD8-  T 
Cells That Become Double Positive  on Activation.  It has been 
argued that during T  cell activation the true percentage of 
CD4 + CD8 + cells is very low, and that doublets of single- 
positive cells make up the majority of the apparent double- 
positive population (17). To test this possibility, CD4 § and 
CD8 + ceils were purified from two congenic rat strains ex- 
pressing different allotypes of the leukocyte common antigen 
(LCA;  CD45).  The  CD8 +  cells  were  obtained  from  the 
strain  PVG.RT1 c (R.T7  ~ or LCA  1.1  allotype)  and  CD4 + 
cells from the strain PVG.RT7  b (RT7  b or I.CA 1.2 allotype). 
After purification, the CD8 +  tLT7' + and CD4 § RT7  b + cells 
were mixed and  activated with  the mitogen. 
Fig. 2 shows the phenotype of the cells after a 3-d incubation 
period in the presence of dexamethasone. The CD4 + CD8 + 
population that was generated accounts for 45% of the cells 
in the culture (Fig. 2 A). Labeling with the mAbs NDS58 
and HIS 41 (Fig.  2 B) was used to investigate the possible 
A  B 
31  45  26  2 
￿9 ::.7  ,_,m 
"  I'  ii~  24' 
..... i  ........ i 
CD8 
c 
29  43 
2  i  26 
..... i  .......  i  ........ 
E 
1  27 
￿9  "  "i 
35::  :i  '::: 
￿9 
...... i  ........ i  ....... 
CD8 
1  71 
..... i  ........ i  ........ 
HIS  41 
D 
1  72 
O 
r 
~25  :  ,  2 
...... I  ........ i  ...... 
F 
25  3 
￿9  k~,'i 
2  ~  70 
..... i  ........ u  ....... 
CD4 
Figure 2.  Activated T calls that express both CD4 and CD8 are not 
artifacts produced by the association of singly labeled cells. CD4 + and 
CD8 + T cells were isolated from congenic rat strains whose leukocytes 
express different alleles of CD45. These calls were then mixed and stimu- 
lated in vitro with Con A and 10 -s M dexamethasone. After 3 d the 
stimulated cells were subjected  to phenotypic analysis by flow cytofluorog- 
raphy. Cells were labeled with: (A) anti-CD4 mAb (ordinate) and anti- 
CD8 mAb (abscissa); (B) anti-CD45 mAb NDS 58, which recognized the 
allele of CD45 on the CD8 + T cells, and mAb HIS 41, which recog- 
nized the alMe expressed by the CD4 + T cells; (C) mAbs HIS 41 and 
anti-CD8; (D) mAbs HIS 41 and anti-CD4; (E) mAbs NDS 58 and anti- 
CD8; (F) mAbs NDS 58 and anti-CD4. 
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phenotype.  This population  amounted  to only 2%  of the 
total.  It  is evident  that  the  few doublets  of cells  are not 
sufficient to account for the great majority of the 45%  of 
cells  coexpressing CD4 and CD8  antigens. 
It was also determined in this experiment  which T  cell 
subset initially single-positive CD4 or CD8, becomes double 
positive. In Fig. 2 C, 43% of the cells express both RT7  b+ 
and CD8 antigen  after activation  in the presence of dexa- 
methasone.  All of the RT7  b- cells express CD8, being the 
CD8+RT7 a+  cells.  Fig.  2  D  shows  the  existence  of two 
populations:  CD4 +  RT7  b  + and CD4- RT7  b-. These results 
show that  all of the RT7  b+ cells,  originally single-positive 
CD4+CD8 -  cells, express the CD4 molecule, and after ac- 
tivation in the presence of dexamethasone, 60% of them, i.e., 
43/(43  +  29), also express the CD8 antigen.  The RT7  b- 
population  is single-positive  CDS+CD4 -.  The  following 
two immunofluorescence analyses confirm the previous results, 
but with the opposite aUotypic marker.  Fig. 2, E and F, show 
that the RT7 ~+ cells express CD8 but not CD4 antigen.  It 
can also be observed that the RT7  a-  is divided into CD8 + 
and CD8- cells. Again, some of the initial CD4 single-posi- 
tive cells express the CD8 molecule, and the RT7'+CD8 + 
cells remain  single positive.  Although  3%  of the cells  are 
CD4 +  CD8 + HT7  ~+, these presumably represent doublets of 
CD4 + and CD8 + cells.  However, because no quadrant  of 
the contour plots in Fig. 2 is completely devoid of cells, there 
is an intrinsic uncertainty in the phenotype of 2-3% of the 
cells examined.  Consequently it is not possible to disprove 
that rare CD8 + cells can become double positive. Qualita- 
tively, the same result was found in the absence of dexameth- 
asone,  but  the  size  of the  CD4+CD8 +  population  was 
smaller than in the presence of the hormone (data not shown). 
It is evident from these results that only the CD4 § cells 
become double positive after activation, and CD8 + cells re- 
main single positive. Dexamethasone does not alter this pat- 
tern, but increases  the percentage of CD4 § cells expressing 
CD8,  as well as the level  of this expression. 
Dexamethasone Induces Expression of CDScr Chains but Not 
CD8~ Chains on Con A-stimulated  CD4 + T  Cells.  To de- 
termine whether CDSB chains, as well as CDSo~ chains, were 
expressed on Con A-activated CD4 + T  cells, use was made 
of mAb 341,  which binds only to CD8 dimers expressing 
the CDSB chain (28). Rat T cells, purified from lymph nodes 
by rosette depletion of cells expressing surface Ig and/or class 
II MHC antigens, were stimulated by Con A in the presence 
or absence of 10 -s M dexamethasone using T  cell-depleted 
splenocytes as a source of accessory cells. After 3 d, the cells 
were harvested, and two-color flow cytofluorography was car- 
ried out using anti-CD4 mAb together with either anti-CD8c~ 
(OXS) or anti-CD8 heterodimer (mAb 341). The result was 
unequivocal: in the presence of dexamethasone 43% of the 
CD4 + T  cells reacted with the anti-CDSc~ chain mAb but 
none with the anti-CD8  heterodimer reagent.  In contrast, 
89%  of the CD4-  cells that  reacted with the anti-CD8o~ 
chain mAb also bound the mAb 341. In the absence of dexa- 
methasone, the result was the same except that, as expected, 
fewer CD4 §  T  cells  expressed the CD8c~ chain  (data not 
shown). Incidentally,  these experiments furnished further evi- 
dence that the CD4CD8 double positives do not arise through 
coincidental observation of single-positive CD4 + and CD8 + 
T  cells. 
Dexamethasone Appears to Induce CD8ot Chain Expression 
by an IL4-inclependent Pathway.  The data in Fig. 2 demon- 
strate  that  some CD4 + T  cells  can express CD8a  chains 
after mitogen activation, and dexamethasone increases  their 
frequency. A similar phenomenon has been described for cloned 
human  CD4 + T  cells after culture in the presence of IL-4 
(38,  39).  It has been reported that  glucocorticoids can in- 
crease Ib4 production by murine T  cells in response to an- 
tigen or anti-CD3 antibody treatment (40, 41), and our ini- 
tial hypothesis was that I1.4 was responsible for the induction 
of CD8a expression during mitogen activation, and that the 
enhancing effects mediated by dexamethasone were possibly 
due to increased Ib4 production. To examine this possibility, 
rat T ceils were activated with Con A alone or in combina- 
tion with Ib4 or dexamethasone, or with both reagents to- 
gether.  Fig.  3  shows that  after Con A  activation,  the fre- 
quency of double-positive cells obtained after dexamethasone 
treatment (Fig. 3 B) was greater than that obtained with I1.4 
(Fig. 3 C). Furthermore,  II--4 suppressed the generation of 
CD4+CD8c~ +  cells  by  dexamethasone,  as  observed  after 
dexamethasone +  Ib4 treatment (Fig. 3 D), and also reduced 
that  obtained after Con A  treatment  alone (Fig.  3, A  and 
C). Although a wide range of IL-4 concentrations were tested, 
it was not possible to demonstrate a positive effect of II.-4 
on the induction of double-positive cells.  Control superna- 
rants, from mock-transfected CHO ceils, were without effect, 
as were rat rI1.2  and rIFN-y (data not  shown). 
Where I1.4 was used in these experiments  it was added 
at the start of the Con A  stimulation  so that  the cytokine 
was in contact with the cells throughout the activation pro- 
cess. Two types of experiments were performed to determine 
whether different results might be obtained if the T cells were 
activated before the addition of the cytokine. In the first of 
these, lymph node cells were incubated with Con A for 3 d, 
washed, and incubated for another 3 d in rat ri1.2. In differ- 
ent wells the  Ib2  was supplemented  with  either  10 -s M 
dexamethasone,  rat  ri1.4,  or a mixture  of these two.  The 
percentage of CD4 +  CD8ol + cells in the various cultures was 
as follows: in I1.2 alone,  16%;  in I1-2  +  dexamethasone, 
31%; in Ib2  +  I1.4, 5%; and in I1.2  +  I1.4  +  dexametha- 
sone,  14%.  In the second type of experiment lymph node 
T cells were stimulated with Con A and the effects of delaying 
the addition  of I1.4 were observed. Six culture conditions 
were studied.  Stimulation  with Con A  for 3 d  alone gave 
16% of double positives, and this was reduced to 6% by the 
addition of I1-4 at the initiation  of the culture. When the 
addition of I1-4 was delayed by 24 h the frequency of double 
positives rose to 11%.  The addition of 10 -s M  dexametha- 
sone to the Con A cultures increased the frequency of double- 
positive CD4 + T  cells to 29%, but the inclusion of I1-4 at 
the initiation of the culture reduced this figure to 11%. Again, 
delaying the addition of the I1-4 by 24 h reduced the level 
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Figure 3.  Effect  of rat rlL-4  on the dexa- 
methasone-induced  expression of CD8o~ chains 
on CD4 + T cells. Rat T cells were stimulated 
with Con A for 72 h in the absence (.4  and 
C) or presence  (B and/9) of 10 -s M  dexa- 
methasone. The effect of including rat rib4 
in the culture medium is shown in C and D. 
After culture the cells were prepared for two- 
color flow cytofluorographic analysis using anti- 
CD4 and anti-CD8 mAbs. The histograms rep- 
resent the fluorescence profiles of the CD4 + 
cells. The numbers on these histograms are the 
percentages  of the CD4 + cells that also  ex- 
press  CD8a chains. 
of inhibition:  20% of cells were CD4+CD8c~ + in these con- 
ditions. 
Consequently, the data do not support the possibility that 
II:4 was responsible for the CD8ot induction during  Con 
A activation in these experiments or for the enhancing effects 
of dexamethasone, but, contrary to our expectation, the lym- 
phokine acted as a negative modulator  of CD8ot chain in- 
duction. The effect of delaying the addition of the IL-4 was 
to reduce its inhibitory  effect but not  to reverse  it. 
Isolated CD4 + Cells Can Be Induced to Express  the CD8cr 
Antigen.  The preceding data show that CD8a chains can 
be detected on the surface of CD4 + cells after mitogen ac- 
tivation. However, because all the previous results were ob- 
tained in the presence of CD8 + cells,  this finding could in 
principle be explained by the passive uptake, by the CD4 + 
cells, of CD8 antigen released by the CD8 + T cell subpopu- 
lation.  The generation of a soluble form of the CD8 mole- 
cule during T cell activation has been described (42), so that 
this trivial explanation for the results did not seem untenable. 
To examine this possibility, CD4 + T cells were isolated, ac- 
tivated with  mitogen using T  cell-depleted  splenocytes as 
feeder cells, and their phenotypes analyzed after a 3-d incu- 
bation  period.  Immunofluorescence  analysis  revealed that, 
under  these  conditions,  activated  CD4 +  cells  expressed 
CD8ot on their membrane (Fig.  4 A), and at a similar level 
to that observed when CD8 + cells were present at the start 
of the culture (Fig.  3 A). Fig. 4 B shows the increase in the 
expression of CD8a chain promoted by dexamethasone.  As 
in the previous experiments, IL-4 was a negative modulator 
of expression both in the absence (Fig. 4 C), and in the pres- 
ence of the glucocorticoid (Fig. 4 D). Since, in this experi- 
ment,  the CD8 + population was removed from the acces- 
sory  cells  and  CD4 +  T  cells,  the  possibility  that  CD8 
antigen is acquired passively by CD4 + cells can be discarded. 
Although in principle the existence of some very small con- 
tamination  by CD8 §  cells  cannot  be excluded,  these cells 
would need an extremely high rate of soluble CD8 produc- 
tion to account for the high level of CD8 expression in highly 
purified CD4 + cells,  comparable with  the level  of expres- 
sion when unfractionated  cells  are analyzed. 
These data are in contrast to a previous report with human 
T  cells, where CD8 expression on CD4 + cells required the 
presence of irradiated CD8 + cells,  or some conditioned su- 
pernatant  from these cells.  In these experiments it was not 
suggested that the CD8 antigen was passively acquired, and 
the demonstration of the biosynthesis of CD8 molecules by 
CD4 + T  cells  supported  this conclusion  (10). 
Expression  of the  CD8 Gene in Activated  CD4 + T  Cells. 
A  B  C  D 
82 
1  0 
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(log fluorescence intensity) 
Figure 4.  CD8 + T cells are not required for 
the induction of CD8a chain expression on 
activated CD4 +  T  cells.  Purified CD4 +  T 
cells were activated by Con A for 72 h in the 
presence ofT cell-depleted accessory calls. For 
the data shown in B and D, dexamethasone was 
included in the culture medium, and in some 
cases (C and D) rat rib4 was also added.  As 
in Fig. 3, the numbers on the histograms are 
the percentages of the CD4 + cells that also 
express CD8c~ chains. 
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by CD4 § cells during activation, and to characterize at what 
level dexamethasone and IL-4 exert their effects, CD8ot chain 
mRNA expression was analyzed by Northern blot in a cell 
culture system similar to that used in Fig. 4.  As shown in 
Fig. 5, CD8c~ chain mRNA was detected from cultures of 
CD4 + T  cells stimulated with Con A  and the level of ex- 
pression was markedly increased by the inclusion of dexa- 
methasone. Furthermore, in accordance with the cell surface 
phenotyping data,  the presence of IL-4 greatly diminished 
CD8c~  chain mRNA  synthesis.  It appears that both dexa- 
methasone and II.-4 influence the transcription of the CD8ot 
chain gene or change the rate of degradation of the mRNA. 
Differential  Expression  of  CD8ot  Chains  on  Activated 
OX22hgehCD4  + and OX22Z~  + Cells.  CD4 + T  cells in 
the rat can be divided into two phenotypical and functional 
subpopulations by the mAb OX22, which recognizes a re- 
stricted epitope on the CD45 molecule. The OX22highCD4 + 
subset mediates graft-vs.-host reactions but provides little or 
no B cell help for secondary antibody responses.  After acti- 
vation it produces IL-2 and IFN-% but expresses little IL4 
mRNA.  In contrast, reciprocal activities and lymphokine 
production are found for the OX221~  + subset, which 
provides help in secondary B cell responses,  produces higher 
levels of Ib4 mRNA,  and lower levels of IL-2 and IFN-3, 
(23,  31,  43). 
Experiments were carried out to determine whether both 
subsets  of CD4 + cells express CD8~ chains during activa- 
tion and whether dexamethasone regulates this induction. 
As Fig.  6,  C  and E,  show,  OX221~  + cells  expressed 
higher levels of CD8ot than did OX22hishCD4 + cells after 
mitogen activation.  However, dexamethasone  increased CD8ot 
expression by both subsets,  with the OX22  ~~  cells again ex- 
Figure 5.  CD8c~  chain  mRNA 
expression  in  purified CD4 + 
T cells. Total cellular mRNA 
was  isolated from the  follow- 
ing sources: lane 1, cortical thy- 
mocytes; lane 2,  unstimulated 
CD4 + T cells; lane 3, CD4 + T 
cells stimulated  with Con A; lane 
4, CD4 + T cells stimulated  with 
Con A plus dexamethasone;  lane 
5, CD4 + T cells stimulated with 
Con A plus rlL-4; lane 6, CD4 § 
T cells stimulated with Con A 
plus dexamethasone plus rlL-4. 
Cells were  cultured  for 72 h as de- 
scribed in Materials and Methods. 
The Northern Blot was probed 
with (a) a rat CD8ot  chain  cDNA 
probe  before  stripping  and reprob- 
ing with (b) a rat B actin cDNA 
probe. 
pressing higher levels of CD8c~ than the OX22hig  h ones (Fig. 
6, D  and F). Fig. 6, A  and B, show the level of CD8c~ ex- 
pression, after Con A and Con A plus dexamethasone treat- 
ment,  on  an  unfractionated  CD4 §  culture,  labeled  with 
OX22 and OX32 mAbs as for the sorted fractions, but not 
separated  on the FACS II  |  These unfractionated CD4 § cells 
expressed on their membranes slightly higher levels of CD8c~ 
chain than the corresponding isolated OX22highCD4 + cells 
(Fig.  6,  C  and D). 
Expression  of CD8cr on the Rat CD4 + MBP-3 Clone.  The 
results presented in the previous sections of this paper were 
obtained after polyclonal activation of fresh lymphocytes. To 
examine the phenomenon of CD8c~ chain induction during 
antigen-dependent activation, use was made of the CD4 + 
MBP-specific done, MBP-3 (34). Fig. 7 shows the results after 
3 d of stimulation with specific antigen: CD8ot was expressed 
at low levels after activation (Fig. 7 A) and this weak expres- 
sion decreased progressively during the resting stage in IL-2- 
containing medium until it reached an undetectable level (data 
not shown). Activation by antigen in Ib4-containing medium 
produced a further slight increase in CD8a expression (com- 
pare Fig. 7, A  and B), but this was less than that observed 
with dexamethasone, either at the 10-s or 10-6 M concen- 
tration (Fig.  7, C and D). However, with the clone, IL-4 did 
not antagonize the effect of dexamethasone as it did with 
freshly  stimulated,  polyclonally  activated  cells  (data  not 
shown). After several rounds of stimulation in the presence 
Con  A  Con  A  +dex 
CIM cells 
OX22~Kh CD4 cells 
OX22~w  CD4  cells 
A 
12% 
........  i  ....... i  ........  L ........ 
E 
~  34% 
Figure 6. 
35% 
D 
30% l 
F 
C  D  8  expression 
Both OX22  l~  and OX22hig  h subsets of CD4 § T cells ex- 
press CD8ot chains on activation. Purified  CD4 + T cells and the OX22  low 
and OX22hig  h subsets thereof  were activated  with Con A in the presence 
of  irradiated  accessory  cells  and examined  after  3 d for their surface  pheno- 
type. Dexamethasone  was added to some  of the cultures  as indicated. The 
interrupted  traces  are the fluorescence  histograms  obtained  using the negative 
control  mAb OX21. The percentages  given  are the frequencies  of specifically 
labeled cells whose  fluorescence  intensities were  brighter than that of the 
brightest 1% of the control sample. 
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Figure 7.  Expression  of CD8 on 
a rat T cell done and the effects of 
dexamethasone and  Ib4.  A rat 
CD4 + T cell clone, specific for 
guinea pig MBP, was stimulated  for 
72 h with specific  antigen. The cul- 
ture medium was supplemented 
with IL-4 or  dexamethasone as 
follows: (.4) stimulation with an- 
tigen alone; (B) antigen plus rat 
rlL-4; (C) antigen plus 10-s M 
dexamethasone; (D) antigen plus 
10-6 M dexamethasone.  The inter- 
rupted traces and the continuous 
line traces are the fluorescence  histograms obtained using, respectively,  a nonreactive mAb (MRC-OX21)  and an anti-CD8 mAb (MRC-OX8) to label 
the cells. The percentages  given indicate the frequency  of cells specifically  labeled  by the anti-CD8 mAb, and the numbers in parentheses  are the channel 
numbers for the peaks in the fluorescence histograms. 
of  I1:4  or  10 -s  M  dexamethasone  (both  cultures  sup- 
plemented with I1:2),  the levels of CD8ol expression were 
similar to those shown in Fig. 7, B and C, respectively, indi- 
cating that prolonging  the time in culture did not lead to 
a further increase in CD8ol expression in the presence of 11:4 
or dexamethasone. 
Discussion 
In this study, data are presented that show a glucocorticoid- 
mediated enhancement of CD8c~ chain expression by CD4 § 
T cells during activation. Experiments were designed to ex- 
dude the possibility that the observed coexpression of CD4 
and CD8oe molecules during mature T  cell activation was 
artifactual.  The results of these experiments  indicated that 
alternative explanations,  such as doublet formation during 
mitogen activation or passive uptake of soluble forms of the 
CD8 molecule by CD4 + cells, were not responsible.  The re- 
maining trivial explanation, that the increased number of cells 
coexpressing CD4 and CDSol in dexamethasone cultures was 
due to selective expansion or preferential survival of a preex- 
isting CD4+CDSo~ § population,  can also be discarded: the 
proliferation and cell recoveries in Con A and Con A  +  dexa- 
methasone cultures were quite similar.  For example, in one 
experiment, stimulation of the cells by Con A alone lead to 
a doubling of cell numbers after 3 d, while the inclusion of 
dexamethasone  at  concentrations  of  10 -s  and  10 -6  M 
yielded, respectively, an increase to 280%  and to 160%  of 
the initial cell numbers. Furthermore, the frequency of double- 
positive cells was not significantly changed by removing cells 
expressing CD8 antigen before culture with mitogen.  Such 
a depletion would be expected to also remove any preexisting 
CD4 +CD8c~ +  cells.  Finally,  CD8c~  expression  by  an 
antigen-activated  CD4 + T  cell clone was also enhanced by 
dexamethasone.  The assumption that the anti-CD8cr  chain 
mAb was not detecting some unexpected crossreactivity was 
substantiated by the finding that mRNA for CD8cr was de- 
tectable at elevated levels in cultures containing double-positive 
cells.  It may be noted also that human T  cell clones of the 
phenotype CD4 + CD8cx + have been described (44). 
It is important  to mention  some apparent  discrepancies 
with respect to other reports. Ib4 has been shown to induce 
the expression of CD8 molecules on human CD4 +dones 
after alloantigen (38) and PHA (39) activation. These studies 
are not closely comparable with the majority of the ones de- 
scribed here because they examined the effects of long-term 
exposure of dones to II-4, whereas we analyzed the pheno- 
type of freshly isolated cells after a 3-d activation period. How- 
ever, the single rat CD4 + T  cell clone that we studied did 
express elevated levels of CDSc~ after several rounds of acti- 
vation in the presence of II.-4, and this result is not qualita- 
tively at variance with the published data on the human clones. 
There is, however, a quantitative difference in that in the pub- 
lished data the human clones expressed much higher levels 
of CD8. At present it is unclear whether there are real differ- 
ences in the response of human and rat CD4 + T cells to II:4 
or whether methodological differences can account for the 
apparent discrepancies.  Further studies are necessary in both 
species. 
Another discrepancy is the derivation  of CD4+CD8o~ + 
cells from purified rat CD4 + T  cells,  without  adding any 
exogenous factor.  Blue et al.  (10) reported the inability of 
purified human CD4*  cells to coexpress the CD8 molecule 
without the addition of irradiated CD8 + cells or some con- 
ditioned supernatant  from CD8 + cells.  The nature of this 
conditioned supernatant  has not been described, and it is a 
possibility that the T cell-depleted splenocytes that we used 
as accessory cells also provide it. However, there is no con- 
sensus on the need for the presence of CD8 + T  cell prod- 
ucts in the induction of double-positive T cells, and the situ- 
ation remains  unresolved. 
The  functional  activities  of the dexamethasone-induced 
double-positive T  cells described in this paper have yet to 
be determined,  but it is notable that  some of the reported 
suppressor  clones  in  human  (45)  and  mouse  (46,  47)  are 
CD4+CD8 + or become so on activation  (48).  In view of 
this correlation between phenotype and function, it is tempting 
to associate the phenotypic changes induced in CD4 + cells 
by dexamethasone, with the immunosuppressive properties 
of glucocorticoids. One CD4+CD8 + suppressor clone (48) 
was generated in the presence of cyclosporine A, another im- 
munosuppressive agent.  CsA has been shown to induce in 
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lografted rats that were tolerant of their allografts (13). Hence, 
it  seems  that  both  immunosuppressive  drugs,  CsA  and 
glucocorticoids, are able to induce a CD4+CD8 + popula- 
tion, and this phenotype is also expressed in many suppressor 
clones.  If coexpression  of CD4 and CD8 is a marker of sup- 
pressor activity, then there may be major significance in the 
recent report that the frequency of MBP-specific T cell lines 
that were CD4+CD8 + was much higher in normal individ- 
uals than in patients with multiple sclerosis (49). In this con- 
text it is notable that when rat CD4 + T cells were fraction- 
ated on the basis of their level of expression of the OX22 
epitope it was the population that was OX22  l~  that pro- 
duced the greater frequency of CD4+CD8ol + double posi- 
tives on activation (Fig.  6).  Cells with the OX221~  + 
phenotype have been shown to prevent autoimmunity in two 
model systems in the rat (50,  51), but it is not known at 
present whether it is those cells that become double positive 
on activation that mediate this protective function. Further, 
because there is probably a higher frequency of memory T 
cells  in  the  OX22  l~  subset  (51),  it  may be  that  only 
memory CD4 + T  cells can be induced to express  CD8o~ 
chains. In any event, a study of the physiological significance 
of the ability of glucocorticoids to enhance CD8ot chain ex- 
pression on CD4 + cells is now required. 
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